Skip to main content

Table 6 Anemia (Hb < 10 g/dl) managements

From: Study the response of Qurevo (ombitasvir, paritaprevir, and ritonavir) in end-stage renal disease patients with hepatitis C virus

Anemia
Management done N %
ESA (added or increased dose) 26 52.00
Blood transfusion 7 14.00
Ribavirin stopped 3 6.00
Ribavirin reduced 1 2.00
  1. ESA erythropoiesis-stimulating agents